Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Aqua Pharmaceuticals, LLC Appoints Ted White as COO, Mark Boyer as Director of Finance

Published: Tuesday, February 12, 2013
Last Updated: Tuesday, February 12, 2013
Bookmark and Share
White moves to the new role from his previous position as Vice President of Sales, while Boyer advances from his former position as Controller.

As COO, White will be responsible for overseeing the daily operation of Aqua and developing business strategies, serving as second-in-command to the company’s President and CEO, Craig Ballaron.

“I can always depend on Ted to be ahead of the curve,” said Ballaron. “He’s a fantastic manager, and his combination of sales savvy and steadfast leadership have helped him move up quickly within the company.”

White joined Aqua in 2011 following a successful 21-year sales career with Novartis Pharmaceutical Corporation, where he led sales teams in new product launches and executed tactics for multiple billion-dollar brands. In July 2010, PharmaVoice magazine named him one of the top 100 inspirational leaders in the health sciences field.

As the new Director of Finance, Boyer, who is a licensed CPA, will manage the company’s budget and lay out operational fiscal policies.

“Having someone with a solid, analytical understanding of both numbers and the pharmaceutical industry in general is invaluable to Aqua,” said Ballaron. “As Controller, Mark demonstrated a knack for both. He’s adept at data analysis and managing corporate funds, so moving to the role of Director of Finance was a natural progression.”

Prior to joining Aqua in 2010, Boyer worked as a Senior Accountant for Teleflex Incorporated’s ARROW International division, where he was responsible for financial reporting, Sarbanes-Oxley compliance and fixed-asset management.

“This is a dynamic time of growth and change for Aqua,” said Ballaron. “I am excited to help write the next phase in our company’s history with Ted and Mark at my side.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Long-Term Culturing of Adult Stem Cells
A new procedure developed by Harvard Stem Cell Institute researchers (HSCI) at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Plant-Based Vaccine Among Front Runners In Search For New Polio Jab
A researcher from Norwich is part of a consortium that has been awarded $1.5 million to develop safer polio vaccines, using a new technique developed at the John Innes Centre.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Better Animal Model to Improve HIV Vaccine Development
Penn study identifies a new tool to produce better HIV vaccine designs.
First Large-Scale Proteogenomic Study of Breast Cancer
The study offers understanding of potential therapeutic targets.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!